Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice
This modification, referred to as BPC-157 ARG, aims to enhance the stability and bioavailability of the peptide, potentially contributing to its effectiveness in experimental settings
In mouse, a NOD.H-2h4 strain prone to AIT and susceptible individuals, excess I increases the number of intrathyroidal infiltrating Th17 and inhibits the development of Treg, causes abnormal expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in thyrocytes, leading to their apoptosis (44, 45)
Choose liposomal formats for ingredients like glutathione and Vitamin C to ensure the nutrients actually reach their destination
doi: 10.1136/jmedgenet-2015-103078 [DOI] [PubMed] [Google Scholar] 67